Popular Trials
Retrospective arm for Heart Failure
Recruiting1 award2 criteria
Minneapolis, Minnesota
The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.
Local Anesthetic
Pain Control Methods for Pancreatic Cancer Surgery
Recruiting1 awardPhase 2
Minneapolis, Minnesota
"This trial compares the use of two pain control methods after pancreas and duodenectomy surgery. One method involves injecting a long-acting local anesthetic between muscle layers in the abdomen (rectus she
Full Analysis set for Dry Eye Syndrome
Recruiting1 award6 criteria
Woodbury, Minnesota
Primary Objective - To assess the proportion of patients with Sjögren's dry eye who demonstrate impaired corneal sensitivity. Secondary Objectives To assess corneal sensitivity via Cochet-Bonnet esthesiometer. To assess tear secretion via Schirmer I test. To assess OPAS questionnaire results.
Popular Filters
Trials With No Placebo
5-HT RBD group for REM Sleep Behavior Disorder
Recruiting1 award6 criteria
Minneapolis, Minnesota
This project will test the hypotheses that people with 5-HT RBD have systemic alpha- synuclein pathology, prodromal DLB signs, and brainstem lesions in regions that control REM sleep. AIM 1 will seek to detect abnormally phosphorylated alpha- synuclein aggregates on targeted skin biopsy in a cohort of people with 5-HT RBD and matched controls (taking SSRIs but without RBD). Aim 2 will use ultra-high field MRI at 7T to examine the pontine region of the coeruleus/subcoeruleus complex for evidence of neurodegeneration as well as segment and parcellate REM sleep related neuronal structures. Aim 3 will test for speech deficits. While these aims are independent we suspect that the severity of autonomic, speech and cognitive deficits will correlate with loss of neuromelanin signal on MRI and pathology on skin biopsy. The investigation is a longitudinal designed study to examine histopathology, neuroimaging changes and speech function from baseline (Time 1) to a follow-up after 30 months (Time 2). A total of 60 individuals, 30 with 5-HT RBD and 30 controls, will be recruited at Time 1, brought back at Time 2, and tested across all Aims at both study visits.
Behavioural Intervention
Speech Manipulation for Hearing Loss
Recruiting1 award1 criteria
Minneapolis, Minnesota
This trial aims to understand how people recognize speech sounds in different contexts. Researchers will study how background noise affects speech perception, especially in people with hearing loss. They will also compare how cochlear implant users
Behavioural Intervention
Personalized Nutrition Therapy for Type 2 Diabetes
Recruiting1 award3 criteria
Minneapolis, Minnesota
This trial aims to test the use of continuous glucose monitoring (CGM) to personalize nutrition therapy for individuals with type 2 diabetes who are not meeting their blood sugar goals. Current nutrition plans often do
Behavioural Intervention
Park Programs for Physical Activity
Recruiting1 award
Minneapolis, Minnesota
This trial aims to study how providing more inclusive and culturally-tailored programs in parks can encourage African American families to be more physically active. The study will involve African American parent-child pairs who will be
Behavioural Intervention
Behavioral Coaching for Heart Attack
Recruiting1 award1 criteria
Minneapolis, Minnesota
This trial will involve sixty adults who recently had a heart attack in three different states. They will be divided into two groups: one group will receive a coaching program for improving mood and health behaviors, while
Behavioural Intervention
Filter Ventilation Changes for Smokers
Recruiting1 award2 criteria
Minneapolis, Minnesota
This trial will test if using different types of filters in cigarettes affects smoking behavior and exposure to harmful substances like nicotine and carbon monoxide in menthol smokers who switch to non-menthol cigarettes. Participants
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.